Skip to main content
. 2021 Jun 16;11(6):112. doi: 10.1038/s41408-021-00504-5

Fig. 1. Tier A, B, and C fusion genes (FGs) detected in the 1000 acute leukemia cases.

Fig. 1

a Tier A, B, and C FGs were identified in 618 samples. Most of them showed 1 fusion event (n = 508), 90 patients harbored 2 fusions, and 16 patients had 3 fusions. Only 3 patients had 4 fusions and 1 patient had 5 fusions. b Venn diagram represented the pathogenicity evaluation of the FGs found in the 618 cases. c A total of 57 distinct recurrent FGs were identified, including 39 tier A, 16 tier B, and 2 tier C FGs, respectively. Fourteen FGs had incidences higher than 1%.